The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Librium 5mg Hard Capsules



Mylan IRE Healthcare LimitedPA2010/041/001

Main Information

Trade NameLibrium 5mg Hard Capsules
Active SubstancesCHLORDIAZEPOXIDE HYDROCHLORIDE
Dosage FormCapsule, hard
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/041/001

Group Information

ATC CodeN05BA Benzodiazepine derivatives
N05BA02 chlordiazepoxide

Status

License statusAuthorised
Licence Issued01/04/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back